glp-1 approved for sleep apnea Efficacy of Receptor agonists in treating Obstructive apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes 5 Benefits of GLP-1 Medications
Description
These findings are encouraging, and must be interpreted cautiously, as many studies cannot separate direct pharmacologic effects from improvements in metabolic health that accompany treatment
In CREDENCE [10], although the risk of amputation was higher overall than in other SGLT2 inhibitor trials, no significant increase in risk was observed with canagliflozin 100 mg vs placebo (HR 1.11, 95% CI 0.79, 1.56)
10.1038/s41591-021-01391-w
They follow a high-profile confrontation between the FDA and Hims & Hers Health, Inc
